Search

Search Results

• Hidradenitis suppurativa: state-of-the-art review and update

  Marco Virone, Elena Zappia, Alberto Di Caro, Davide Carlesimo, Nicoletta Bernardini, Giovanni Pellacani, Antonio Giovanni Richetta, Steven Paul Nisticò, Annunziata Dattola

  27-08-2025

  https://doi.org/10.4081/dr.2025.10328

  1337

  PDF: 853

  HTML: 18
• 

  Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data

  Aikaterini Kyriakou, Anastasia Trigoni, Nikiforos Galanis, Dimitrios Sotiriadis, Aikaterini Patsatsi

  01-10-2018

  https://doi.org/10.4081/dr.2018.7859

  2132

  PDF: 1099

  HTML: 89

• Health-related quality of life and clinical characteristics of hidradenitis suppurativa in a pediatric population

  Anna Dattolo, Francesca Sampogna, Simona Mastroeni, Luca Fania, Davide Ciccone, Damiano Abeni

  16-10-2024

  https://doi.org/10.4081/dr.2024.10086

  891

  PDF: 545

  HTML: 39
• 

  Certolizumab to treat hidradenitis suppurativa

  Asem Shadid, Saud Alobaida, Yousef Binamer

  27-10-2022

  https://doi.org/10.4081/dr.2022.9566

  1985

  PDF: 758

  HTML: 54
• 

  Secondary prevention of hidradenitis suppurativa

  Hjalmar Kurzen, Marina Kurzen

  25-10-2019

  https://doi.org/10.4081/dr.2019.8243

  3122

  PDF: 1254

  HTML: 45

• Ultrasound monitoring of hidradenitis suppurativa fistulas in treatment with adalimumab

  Raffaele Dante Caposiena Caro, Giulia Bazzacco, Enrico Zelin, Vanessa Mazzoletti, Nicola Di Meo, Iris Zalaudek

  11-04-2025

  https://doi.org/10.4081/dr.2025.10124

  699

  PDF: 451

  HTML: 15
• 

  Hidradenitis suppurativa in a patient with hyperandrogenism, insulin-resistance and acanthosis nigricans (HAIR-AN syndrome)

  Yaser Taha Melibary

  25-06-2018

  https://doi.org/10.4081/dr.2018.7546

  1943

  PDF: 756

  HTML: 360

• Exploring the connection between hidradenitis suppurativa and erythema nodosum: a case report

  Mitchell Hanson, McKenzie E. Maloney, Louis Kuchnir

  08-02-2024

  https://doi.org/10.4081/dr.2024.9866

  1249

  PDF: 778

  HTML: 41

• Nightmares caused by isotretinoin in treating hidradenitis suppurativa: a case report and clinical insights

  Fawaz Aljehani, Shumukh Alqahtani, Sara Alharbi, Seham Alsulami

  06-12-2024

  https://doi.org/10.4081/dr.2024.10171

  1859

  PDF: 492

  HTML: 59

• Can hydradenitis suppurativa be associated with inflammatory joint involvement? Report of a case series and review of the literature

  Dario Graceffa, Martina Silvestri, Norma Cameli, Viviana Lora, Antonio Cristaudo, Claudio Bonifati, Carlo Cota, Pier Luigi Saraceni

  11-09-2023

  https://doi.org/10.4081/dr.2023.9815

  838

  PDF: 447

  HTML: 24
• 

  Possible relationship between poor skin disorders prognosis and serum zinc level: a narrative review

  Mohammed Al Abadie, Zinah Sharara, Miriam Al Abadie, Patrick A. Ball, Hana Morrissey

  06-07-2022

  https://doi.org/10.4081/dr.2022.9512

  2256

  PDF: 1116

  HTML: 281

• Adalimumab-induced facial erysipelas and its successful resolution with azithromycin in a 19-year-old female

  Caterina Mariarosaria Giorgio, Anna Balato, Gaetano Licata, Giuseppe Argenziano, Vittorio Tancredi, Eugenia Veronica Di Brizzi

  21-02-2025

  https://doi.org/10.4081/dr.2025.10278

  507

  PDF: 327

  HTML: 25
• 

  A case of perifolliculitis capitis abscedens et suffodiens and acne conglobata effectively treated with a tumor necrosis factor α inhibitor

  Shinpei Miura, Kanako Tsunoda, Hiroo Amano

  05-06-2023

  https://doi.org/10.4081/dr.2023.9699

  794

  PDF: 478

  HTML: 33

• When anti-tumor necrosis factor-α backfires: paradoxical psoriasis and psoriatic arthritis in a patient with hidradenitis suppurativa

  Chiara Del Re, Vincenzo Filastro, Gaia Fasano, Giancarlo Valenti, Domenico D'Amico

  11-09-2026

  https://doi.org/10.4081/dr.2026.10808

  396

  PDF: 168

• Hidradenitis suppurativa characterized by type 2-skewed inflammatory features when associated with atopic dermatitis: critical appraisal of a dupilumab-treated case report

  Niccolò Gori, Elena Ippoliti, Flaminia Antonelli, Ludovica Manieri, Ketty Peris

  15-07-2026

  https://doi.org/10.4081/dr.2026.10292

  339

  PDF: 187

• Upadacitinib for the management of refractory hidradenitis suppurativa, psoriasis, and pyoderma gangrenosum

  Giorgia Sbarra, Edoardo Mortato, Francesco Loconsole

  03-02-2026

  https://doi.org/10.4081/dr.2026.10314

  626

  PDF: 415

• Non-invasive imaging for monitoring nodular inflammatory lesions in hidradenitis suppurativa

  Giuseppe Rizzuto, Federica Rega, Nevena Skroza, Concetta Potenza, Steven Paul Nisticò, Giovanni Pellacani, Nicoletta Bernardini, Annunziata Dattola

  30-01-2026

  https://doi.org/10.4081/dr.2026.10390

  523

  PDF: 323

• The top 100 most cited articles in acne vulgaris: a bibliometric analysis

  Sapir Itzhaki Gabay, Barak Zlakishvili, Yuliya Valdman-Grinshpoun , Amir Horev

  15-02-2024

  https://doi.org/10.4081/dr.2024.9886

  3361

  PDF: 615

  SUPPLEMENTARY MATERIAL: 201

  HTML: 26

• 61 | SUNITINIB-INDUCED FOLLICULAR OCCLUSION DISORDER OF THE FACE: A CASE REPORT Z. Fratton^1|2, A. Bolzon^2|3, A. Corrà², G. Frattin^2|3, L. Germi², L. Gnesotto², D. Lai², G. Mioso², E. Pezzolo², L. Schiesari² | ¹Department of Medicine, Institute of Dermatology, University of Udine, Italy; ²Dermatology Unit, Ospedale San Bortolo, Vicenza, Italy; ³Unit of Dermatology, Department of Medicine, University of Padova, Italy

  Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica

  24-09-2026

  https://doi.org/10.4081/dr.2026.11070

  131

  PDF: 109

• Diverse clinical manifestations of acquired vulvar lymphangioma: a report of five cases in Vietnamese women

  Tho Thi Thanh Nguyen, Anh Nguyen Ngoc Hoang, Thu Nguyen Anh Luu, Thuy Thi Phan Nguyen, Em Van Loi Doan, Tu Nguyen Anh Tran, Hao Trong Nguyen

  29-01-2024

  https://doi.org/10.4081/dr.2024.9888

  945

  PDF: 488

  HTML: 27
• 

  Utilization of health services for skin disorders during military operations. A population- based study

  Amir Horev, Shanny Edan-Reuven, Ron Eshel, Lena Novack

  22-12-2020

  https://doi.org/10.4081/dr.2020.8648

  2186

  PDF: 491

  Supplementary Files: 172

  HTML: 7
• 

  Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces

  Martina Vispi, Teresa Corradin, Camilla Peccianti, Luca Feci, Laura Casini, Chiara Pisani, Susanna Fabbroni, Paola Corsetti, Margherita Croatto, Michele Pellegrino

  25-06-2020

  https://doi.org/10.4081/dr.2020.8642

  1422

  PDF: 776

  HTML: 19

• Targeting JAK/STAT signaling: ruxolitinib cream in the management of concurrent vitiligo and discoid lupus erythematosus

  Andrea Bassi, Vincenzo Piccolo, Grazia Gallippi, Giuseppe Argenziano, Michela Magnano, Carlo Mazzatenta

  11-09-2025

  https://doi.org/10.4081/dr.2025.10458

  445

  PDF: 359

  HTML: 24

• Cutaneous tuberculosis, different clinical spectrum of the same disease: the importance of pre-test probability

  Carla Rosero, Lucy Baldeón, Valeria Alulema, Adriana Rueda, Lorena Vaca, Daniela Galarza, Cesar Prócel

  24-01-2024

  https://doi.org/10.4081/dr.2024.9770

  1553

  PDF: 580

  HTML: 52
• 

  4th National Congress of the Bulgarian Society for Dermatologic Surgery, Sofia, 12th March 2022 with main topics: one step melanoma surgery and drug induced melanoma

  Georgi Tchernev, Nikhil Oliveira, Lorraine Joseph Kandathil, James W. Patterson, Jose Carlos Cardoso, Simona Kordeva, Ivan Pidakev, Konstantin Stavrov

  23-11-2022

  https://doi.org/10.4081/dr.2022.9542

  892

  PDF: 351

  HTML: 29